Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Tadalafil vs. Tadalafil With Sildosin in the Management of Moderately and Severely Symptomatic Patients of Prostatic Hyperplasia

NCT04577040 is registered in ClinicalTrials.gov with Menoufia University as lead sponsor.

NCT NCT04577040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04577040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Tadalafil vs. Tadalafil With Sildosin in the Management of Moderately and Severely Symptomatic Patients of Prostatic Hyperplasia
Lead sponsor
Menoufia University
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2020
Completion date
October 1, 2022
Enrollment
400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

safety and efficacy of tadalafil vs. tadalafil with sildosin in the management of moderately and severely symptomatic patients of prostatic hyperplasia